Trial AIO-PAK-0313 NEONAX

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

AIO-PAK-0313 NEONAX

Full title

Neoadjuvante plus adjuvante oder nur adjuvante Therapie mit nab? Paclitacel plus Gemcitabine bei resektablem Bauchspeicheldrüsenkrebs ? eine prospektive, randomisierte, kontrollierte Phase II Studie der AIO Arbeitsgruppe Pankreaskarzinom

Responsible organization

2. Med 2. Med Ismaninger Str. 22 81675 München Germany

Indications

Classification	Code	Description
-		Pancreas carcinoma

Trial design

Phase

Status

Recruitment finished

Votes

Institutional review board - vote

Positive

Institutional review board - vote date

2015-01-19

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Therapy

Chemo - Therapieart: neoadjuvant

Participants

	Function	Prename	Surname	Organization
	Responsible contact	Hana	Algül	2. Med 2. Med Ismaninger Str. 22 81675 München Germany